YOUR HEALTH. A MORE INFORMED VIEW.
Blood tests and genital testing, connected.
CLINICAL AUTHORDr Nirupama SabhapathySpecialist Clinical Pathology
Collected around you.THE PURPOSE BEHIND THE PANEL.
This package combines blood-based HIV, hepatitis and syphilis testing with the fourteen-target genital PCR panel and routine urinalysis.
5named targets5 listed entries
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
1named target1 listed entry
This view contains 1 entry. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
14named targets14 listed entries
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
6laboratory assays6 included assays
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase.
Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
KNOW EXACTLY WHAT YOU ARE CHOOSING.
The 20-entry package display combines five blood-test infection entries, fourteen genital PCR targets and one routine urinalysis panel. The urine panel has its own nested measurements; these are not added to the headline count.
20 named target entries · 6 included assays · 20 Markers
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 1 entry. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Looks for hepatitis B surface antigen. A reactive result needs clinical follow-up; this does not measure vaccine immunity.
Read the test guideLooks for hepatitis C antibodies. A reactive result may reflect previous or current infection and usually needs an RNA test to establish current infection.
Read the test guideCombines HIV-1/2 antibody testing with p24 antigen testing. Reactive results need the appropriate confirmation pathway; very recent infection may not yet be detectable.
Read the test guideA non-treponemal syphilis blood test used in a clinical testing pathway. Reactive results need interpretation with appropriate confirmatory testing.
Read the test guideLooks for fourteen listed genital targets. Some may represent colonisation rather than a symptomatic infection; specimen and clinical context matter.
Read the test guideReports 21 physical, chemical and microscopic urine findings. This is routine urinalysis, not a urine culture.
INCLUDED COMPONENTS
Try a test or target name, or choose another health focus.
Checking a prescription?
Let’s make sure it matches.
THE RIGHT START DEPENDS ON YOU.
Choose the investigation around the question you want to discuss. Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
This package combines blood-based HIV, hepatitis and syphilis testing with the fourteen-target genital PCR panel and routine urinalysis.
Compare the full included list with your clinician’s request. Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
Bring earlier results and the relevant symptom or treatment history. The clinician can decide whether this scope, a smaller test selection or a different investigation is the most useful next step.
MAKE THE SAMPLE COUNT.
Preparation follows the actual specimen and tests in STD Advanced 20. Confirm your personal instructions before collection.
A personal checklist. Your care team confirms the instructions.
YOUR COLLECTION. YOUR CHOICE.
Both routes lead to the same defined package. Choose the location during checkout; this package waives the collection fee for its visit.
YOUR PLACE. THE SAME LABORATORY PATHWAY.
Discuss collection at your home, hotel or workplace in Dubai. The care team confirms the appropriate specimen, preparation and collection arrangements for this package.
Across DubaiTHE LABORATORY. READY TO WELCOME YOU.
Intel Lab · Deira
101–102, Al Hawai Building, Al Rigga Road, Al Muraqqabat, Deira, Dubai
DEIRA · DUBAI101–102Al Hawai Building
Al Rigga Road
FROM BOOKING TO UNDERSTANDING.
Follow STD Advanced 20 from your care bag to an informed conversation.
The right package. The right person.
Add STD Advanced 20 to your care bag. Book for yourself or assign the package to someone else. The care team can help match the selection to a request or prescription.
Preparation follows the test.
Confirm the instructions for blood + urine and the appropriate collection arrangements. Correct identification, specimen choice and timing support a useful result.
Laboratory work, behind the finding.
Intel Lab processes the sample and checks the report. The package lists 48 hours; collection timing and any additional laboratory checks may affect release.
A finding, placed in your context.
Read the report with the reason for testing. A clinician can explain unexpected findings, relevant limitations and whether any further assessment is appropriate.
MORE THAN A LIST OF NUMBERS.
Your report brings the measurements together. Explore the findings below to see which questions make the report more meaningful.
UNDERSTANDING YOUR REPORTBlood
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
UNDERSTANDING YOUR REPORTUrine
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 1 entry. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
UNDERSTANDING YOUR REPORTUrine
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 14 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
UNDERSTANDING YOUR REPORTBlood / Urine
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase. Routine urinalysis is not a culture; panel coverage and window periods still need individual consideration.
THE NEXT STEP IS PERSONAL.
Connect the laboratory findings with the reason for this specific test. A report supports the next clinical conversation; it does not decide it for you.
Review the blood screens, genital molecular findings and routine urine results as distinct investigations. Each has its own confirmation and follow-up considerations; one result does not replace the others.
Discuss this result with a clinician who knows the reason for testing. Further investigations or follow-up depend on the actual findings and your circumstances.
THE LABORATORY BEHIND YOUR RESULTS.
Intelligent Care brings the collection to you. Intel Lab brings the laboratory pathway, from sample handling to reporting.
Accurate patient details, the correct specimen and clear collection instructions are the first part of a reliable laboratory pathway. Follow the collection team’s instructions for the specimens required by this panel.
The laboratory’s analytical work and quality processes support the measurements in the report. Explore the laboratory’s published quality standards and accreditation scope for the detail behind its services.
Reporting connects the laboratory findings with their clinical use. Unexpected or significant results may need additional checks or communication with the referring clinician.
EXPERTISE WITH A NAME.
Laboratory content belongs with laboratory expertise. Explore the clinical profiles and their Dubai Health Authority directory records.
Clinical author
Laboratory Director · Intel Lab
Dr Nirupama Sabhapathy is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her published Intel Lab profile describes more than 25 years in medicine and her role as Laboratory Director.
Clinical reviewer
Specialist Clinical Pathology · Intel Lab
Dr Joyce Jose is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her public professional record includes pathology practice in the UAE and earlier experience as a professor at Gulf Medical University.
CHOOSE BY PURPOSE, NOT JUST COUNT.
Related packages may ask different questions. Compare their actual scope and discuss which, if any, is appropriate for you.
You are viewingA 20-marker combined work-up pairing blood serology (HIV, hepatitis B & C, syphilis) with a 14-target genital PCR panel and urinalysis: a complete…
A confidential 5-in-1 blood screen for the core blood-borne STIs: HIV (1 & 2), hepatitis B, hepatitis C and syphilis.
Our most comprehensive 28-target STI and genital-flora PCR panel, adding candida species, bacterial-vaginosis organisms and additional viruses on top…
A combined urine PCR package covering 45 named organism targets and 12 selected antibiotic-resistance genes, with clinician-led interpretation.
Choosing for a particular need?
We can help you read the options.
BEFORE YOU BOOK.
Preparation, sample types, timing and what the package does—and does not—include.
Blood tests and genital testing, connected. The full named inventory on this page is the scope of the package.
The package display counts named infection/target entries and urinalysis as one item. Urinalysis itself reports multiple findings; the nested list explains these without adding them to the headline count.
Yes. Blood serology and the urine-based components use different specimens. Follow the team’s instructions for each.
No. Routine urinalysis describes physical, chemical and microscopic findings; a culture is a different investigation.
No. The appropriate timing varies by infection and method. A clinician may advise repeat testing for particular exposures.
The PCR specimen and routine urinalysis may have different collection requirements. Ask the team whether separate labelled samples are needed.
Yes. Choose home collection across Dubai or a visit to Intel Lab in Deira. Any health package waives the collection fee for its own visit; separate appointments are assessed separately.
The package price is AED 699; the listed turnaround is 48 hours. Confirm collection and processing arrangements with the team. Turnaround is not a guarantee that every result will be released at one exact time.
Review relevant findings with a qualified clinician alongside the reason for testing, symptoms, medicines and prior results. The report may lead to reassurance about the tested question, confirmation, a targeted investigation or follow-up—not an automatic treatment decision.
YOUR NEXT STEP. AROUND YOU.
STD Advanced 20 · 20 Markers · Blood + Urine